Cite
HARVARD Citation
Arribas, A. et al. (n.d.). PQR309, idelalisib, duvelisib and ibrutinib lead to similar gene expression changes in activated B-cell like (ABC) diffuse large B-cell lymphoma (DLBCL). European journal of cancer. pp. S39-. [Online].